Trioplus Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2013.
2013 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Trioplus Pharmaceuticals Private Limited

Trioplus Pharmaceuticals Private Limited, a active private limited company, was established on 23 July 2013 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the professional, scientific and technical sector, it holds CIN: U74999MH2013PTC246040. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Kunal Surendra Mehra (Director), Neelav Rajmohan Agarwal (Director). It holds ₹9.86 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Unit No.106, Samruddhi Commercial Complex, Chincholi Bunder Road, Mindspace, Malad, (West),, Mumbai, Maharashtra, 400064.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2013PTC246040

  • Registration Number

    246040

  • Incorporation Date

    23 July 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 6 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 9.86 M
  • Revenue Growth **** -47.71%
  • Profit Growth **** -103.98%
  • Ebitda **** 50.63%
  • Net Worth -1.09%
  • Total Assets -32.31%
Company report

Trioplus Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Trioplus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Trioplus Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Kunal Surendra Mehra Director 23 Jul 2013 Current
Neelav Rajmohan Agarwal Director 23 Jul 2013 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Trioplus Pharmaceuticals.

Trioplus Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 47.71% decrease. The company also saw a substantial fall in profitability, with a 103.98% decrease in profit. The company's net worth dipped by a decrease of 1.09%.

Trioplus Pharmaceuticals revenue growth over time
Trioplus Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -47.71%
*******
*******
*******
*******
Revenue from Operations
*******
 -46.66%
*******
*******
*******
*******
Total Assets
*******
 -32.31%
*******
*******
*******
*******
Profit or Loss
*******
 -103.98%
*******
*******
*******
*******
Net Worth
*******
 -1.09%
*******
*******
*******
*******
EBITDA
*******
 50.63%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Trioplus Pharmaceuticals?

Unlock access to Trioplus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹9,856,500.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.99 Cr
Latest Charge Details
Date Lender Amount Status
21 Jan 2022 Hdfc Bank Limited ₹2.01 M Open
04 Oct 2021 Hdfc Bank Limited ₹1.85 M Open
31 Mar 2018 Hdfc Bank Limited ₹6.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Trioplus Pharmaceuticals?

Unlock and access historical data on people associated with Trioplus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Trioplus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trioplus Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Trioplus Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Trioplus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Trioplus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 2.01 M with Charge ID 100534281 was registered on 21 Jan 2022. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 1.85 M with Charge ID 100540390 was registered on 04 Oct 2021. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 6.00 M with Charge ID 100173878 was registered on 31 Mar 2018. was documented.

  • Director Appointment

    Kunal Surendra Mehra was appointed as a Director was appointed as a Director on 23 Jul 2013 & has been associated with this company since 12 years 6 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Trioplus Pharmaceuticals Private Limited?

The CIN of Trioplus Pharmaceuticals Private Limited is U74999MH2013PTC246040.

Where is Trioplus Pharmaceuticals Private Limited headquartered?

Trioplus Pharmaceuticals Private Limited is headquartered at Unit No.106, Samruddhi Commercial Complex, Chincholi Bunder Road, Mindspace, Malad, (West),, Mumbai, Maharashtra, 400064.

When was Trioplus Pharmaceuticals Private Limited incorporated?

Trioplus Pharmaceuticals Private Limited was incorporated on 23 July 2013.

Who are the current directors of Trioplus Pharmaceuticals Private Limited?

The current directors of Trioplus Pharmaceuticals Private Limited are

What is the primary industry of Trioplus Pharmaceuticals Private Limited?

The primary industry of Trioplus Pharmaceuticals Private Limited is Professional, Scientific And Technical.

Is Trioplus Pharmaceuticals Private Limited a listed company?

Trioplus Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Trioplus Pharmaceuticals Private Limited?

The authorized capital of Trioplus Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Trioplus Pharmaceuticals Private Limited?

The compliance status of Trioplus Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available